{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal ALLO-ASC-DFU",
            "NStudiesAvail": 430108,
            "NStudiesFound": 13,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 13,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "This is a phase II single-blinded study to evaluate the efficacy and safety of ALLO-ASC-DFU in patients with Diabetic Foot Ulcer, compared to standard therapy."
                        ],
                        "BriefTitle": [
                              "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "October 2016"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT02619877"
                        ]
                  },
                  {
                        "Rank": 2,
                        "BriefSummary": [
                              "This is a phase III double-blind study to evaluate the efficacy and safety of ALLO-ASC-DFU in patients with Diabetic Foot Ulcer, compared to placebo therapy."
                        ],
                        "BriefTitle": [
                              "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers."
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 30, 2021"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT03370874"
                        ]
                  },
                  {
                        "Rank": 3,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 1 clinical trial (ALLO-ASC-DFU-101) for 23 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "July 31, 2017"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT03183726"
                        ]
                  },
                  {
                        "Rank": 4,
                        "BriefSummary": [
                              "This clinical trial is a Phase II controlled, parallel, open-label trial, designed to test the efficacy and safety of ALLO-ASC-DFU and conventional therapy in Deep Second-degree burn wound subjects."
                        ],
                        "BriefTitle": [
                              "A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Burn Injury"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT02619851"
                        ]
                  },
                  {
                        "Rank": 5,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 2 clinical trial (ALLO-ASC-DFU-201) for 23 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "August 31, 2018"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT03183804"
                        ]
                  },
                  {
                        "Rank": 6,
                        "BriefSummary": [
                              "This is a phase 2 double-blind clinical study to evaluate the efficacy and Safety of ALLO-ASC-SHEET in subjects with Diabetic Foot Ulcers, compared to placebo therapy."
                        ],
                        "BriefTitle": [
                              "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers"
                        ],
                        "CentralContactEMail": [
                              "armstrong@usa.net"
                        ],
                        "CentralContactName": [
                              "David G. Armstrong, MD.Ph D."
                        ],
                        "CentralContactPhone": [
                              "(+1)5203059393"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 30, 2022"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT03754465"
                        ]
                  },
                  {
                        "Rank": 7,
                        "BriefSummary": [
                              "This is a phase I/II open-label study to evaluate the efficacy and safety of ALLO-ASC-DFU in patients with Dystrophic Epidermolysis Bullosa."
                        ],
                        "BriefTitle": [
                              "Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa"
                        ],
                        "CentralContactEMail": [
                              "kimsc@yuhs.ac"
                        ],
                        "CentralContactName": [
                              "Su Chan Kim, PhD."
                        ],
                        "CentralContactPhone": [
                              "+82 2 2019-3362"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 2017"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Dystrophic Epidermolysis Bullosa"
                        ],
                        "ConditionAncestorId": [
                              "D000012868",
                              "D000000013",
                              "D000012873",
                              "D000030342",
                              "D000012871",
                              "D000012872",
                              "D000003095",
                              "D000003240"
                        ],
                        "ConditionAncestorTerm": [
                              "Skin Abnormalities",
                              "Congenital Abnormalities",
                              "Skin Diseases, Genetic",
                              "Genetic Diseases, Inborn",
                              "Skin Diseases",
                              "Skin Diseases, Vesiculobullous",
                              "Collagen Diseases",
                              "Connective Tissue Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC16",
                              "BC17",
                              "All",
                              "BC05",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT02579369"
                        ]
                  },
                  {
                        "Rank": 8,
                        "BriefSummary": [
                              "This is a phase I open-label study to evaluate the safety of ALLO-ASC-DFU in diabetic foot ulcers patients. ALLO-ASC-DFU is a hydrogel sheet containing allogenic adipose-derived mesenchymal stem cells. Adipose-derived stem cells have anti-inflammatory effect and release growth factors such as vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), which can enhance wound healing and regeneration of new tissue, finally may provide an new option in treating a diabetic foot ulcer."
                        ],
                        "BriefTitle": [
                              "Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "July 2015"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT02394886"
                        ]
                  },
                  {
                        "Rank": 9,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 1 clinical trial(ALLO-ASC-BI-101) for 23 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 2017"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Burn"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT03183622"
                        ]
                  },
                  {
                        "Rank": 10,
                        "BriefSummary": [
                              "This is a phase I study to evaluate the safety of ALLO-ASC-DFU for the treatment of deep second-degree burn wound patients. ALLO-ASC-DFU is a hydrogel sheet containing allogenic adipose-derived mesenchymal stem cells. Adipose-derived stem cells release growth factors such as vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), which can enhance wound healing and regeneration of new tissue, finally may provide a new option in treating a burn."
                        ],
                        "BriefTitle": [
                              "A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "October 2015"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Burn"
                        ],
                        "ConditionAncestorId": [
                              "D000014947"
                        ],
                        "ConditionAncestorTerm": [
                              "Wounds and Injuries"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT02394873"
                        ]
                  },
                  {
                        "Rank": 11,
                        "BriefSummary": [
                              "This is a phase III double-blind study to evaluate the efficacy and safety of ALLO-ASC-DFU in patients with Diabetic Wagner grade 2 Foot Ulcer, compared to placebo therapy."
                        ],
                        "BriefTitle": [
                              "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers."
                        ],
                        "CentralContactEMail": [
                              "pshan@kumc.or.kr"
                        ],
                        "CentralContactName": [
                              "SeungKyu Han, MD. Ph D"
                        ],
                        "CentralContactPhone": [
                              "+82-02-2626-3333"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 31, 2021"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Diabetic Foot Ulcer"
                        ],
                        "ConditionAncestorId": [
                              "D000010335",
                              "D000003925",
                              "D000014652",
                              "D000002318",
                              "D000007871",
                              "D000012883",
                              "D000012871",
                              "D000048909",
                              "D000003920",
                              "D000004700",
                              "D000003929",
                              "D000005534"
                        ],
                        "ConditionAncestorTerm": [
                              "Pathologic Processes",
                              "Diabetic Angiopathies",
                              "Vascular Diseases",
                              "Cardiovascular Diseases",
                              "Leg Ulcer",
                              "Skin Ulcer",
                              "Skin Diseases",
                              "Diabetes Complications",
                              "Diabetes Mellitus",
                              "Endocrine System Diseases",
                              "Diabetic Neuropathies",
                              "Foot Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC14",
                              "BC17",
                              "BC19",
                              "All",
                              "BC23",
                              "BC18",
                              "BC10",
                              "BC05"
                        ],
                        "NCTId": [
                              "NCT04569409"
                        ]
                  },
                  {
                        "Rank": 12,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 2 clinical trial (ALLO-ASC-BI-201) for 23 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Burn"
                        ],
                        "ConditionAncestorId": [],
                        "ConditionAncestorTerm": [],
                        "ConditionBrowseBranchAbbrev": [
                              "BC26",
                              "All"
                        ],
                        "NCTId": [
                              "NCT03183648"
                        ]
                  },
                  {
                        "Rank": 13,
                        "BriefSummary": [
                              "This is an open-label follow up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 1/2 clinical trial(ALLO-ASC-EB-101) for 24 months."
                        ],
                        "BriefTitle": [
                              "A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial"
                        ],
                        "CentralContactEMail": [
                              "kimsc@yuhs.ac"
                        ],
                        "CentralContactName": [
                              "Su Chan Kim, PhD"
                        ],
                        "CentralContactPhone": [
                              "82 2 2019 3362"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "June 2020"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Dystrophic Epidermolysis Bullosa"
                        ],
                        "ConditionAncestorId": [
                              "D000012868",
                              "D000000013",
                              "D000012873",
                              "D000030342",
                              "D000012871",
                              "D000012872",
                              "D000003095",
                              "D000003240"
                        ],
                        "ConditionAncestorTerm": [
                              "Skin Abnormalities",
                              "Congenital Abnormalities",
                              "Skin Diseases, Genetic",
                              "Genetic Diseases, Inborn",
                              "Skin Diseases",
                              "Skin Diseases, Vesiculobullous",
                              "Collagen Diseases",
                              "Connective Tissue Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC16",
                              "BC17",
                              "All",
                              "BC05",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT03183934"
                        ]
                  }
            ]
      }
}